SAM
LGND icon

Simplify Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History

Simplify Asset Management’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-6,786
Closed -$1.2M – 153
2025
Q3 		$1.2M Buy
6,786
+816
+14% +$121K 0.02% 75
2025
Q2 		$679K Sell
5,970
-646
-10% -$69K 0.03% 71
2025
Q1 		$696K Buy
+6,616
New +$748K 0.03% 70

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Simplify Asset Management's LGND Position: Q4 2025 in Review

Simplify Asset Management sold out of Ligand Pharmaceuticals (LGND) in Q4 2025, closing a stake of 6,786 shares — an estimated $1.2M sold.

Simplify Asset Management first reported a position in LGND in Q1 2025 and held it in 3 quarters. The position peaked at $1.2M in Q3 2025. 350 funds tracked by Wall St. Rank hold LGND as of Q4 2025.

  • Simplify Asset Management reported no remaining Ligand Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Simplify Asset Management sold 6,786 Ligand Pharmaceuticals shares in Q4 2025, an estimated $1.2M.
  • Simplify Asset Management first reported a position in Ligand Pharmaceuticals in Q1 2025 and held it in 3 quarters.
  • Simplify Asset Management's Ligand Pharmaceuticals position peaked at $1.2M in Q3 2025.
  • 350 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2025.

Based on Simplify Asset Management's 13F filing for Q4 2025, filed 9 Feb 2026.